ClinicalTrials.gg
CompletedNCT01427985Updated Apr 6, 2016

Influence of Premedication Protocols for Neonatal Endotracheal Intubation on Cerebral Oxygenation

A Phase 4 interventional study of Atropine, Fentanyl, Mivacurium and Atropine, Fentanyl, Mivacurium in Newborn, Preterm and Intubation, sponsored by University of Ulm. Completed at 1 site in Germany. Open to participants aged Up to 44 Weeks. Per ClinicalTrials.gov, last updated 2016-04-06.

Sponsored by University of Ulm · Phase 4, Interventional, and Treatment

Phase
Phase 4
Study type
Interventional
Enrollment
24
Allocation
Randomized
Ages
Up to 44 Weeks
Sex
All
01

Study summary

The purpose of this study is to examine the influence of premedication drugs Atropin, Fentanyl and Mivacurium and of endotracheal intubation on cerebral oxygenation and cardiac output in term and preterm newborn infants. Two different protocols of premedication are compared.

Read the detailed description

Influence of the following procedures will be examined:

  • Application of Atropin
  • Application of Fentanyl
  • Application of Mivacurium
  • possible desaturation and / or bradycardia during intubation attempts
  • restoration of arterial oxygen saturation and / or heart rate after succesful intubation

We aim to examine the change of the following parameters by the use of electrical cardiometry:

  • stroke volume
  • cardiac output

We compare two different premedication protocols and we evaluate the impact of these protocol on the time needed for intubation and on intubation difficulties .

02

Conditions studied

  • Newborn
  • Preterm
  • Intubation

Browse trials for

03

In context

Premature Birth

2,610 studies on the registry are indexed under Premature Birth; 507 are open to participants now.

This study's enrollment of 24 is below the median of 84 across 1,722 interventional studies indexed under Premature Birth.

Browse Premature Birth studies →

Lead sponsor

University of Ulm is the lead sponsor of 143 studies on the registry; 25 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
Up to 44 Weeks
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • newborn infant below 44 weeks postmenstrual age
  • indication for elective or semi-elective endotracheal Intubation
  • parental informed consent

Exclusion criteria

Exclusion Criteria:

  • emergency intubation
05

Study design

Phase
Phase 4
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
24 participants (actual)

Study arms

  • Experimental
    Relaxation followed by analgosedation

    Give Atropin, then Mivacurium, immediately followed by Fentanyl

    Drug: Atropine, Fentanyl, Mivacurium

  • Active comparator
    Analgosedation followed by Relaxation

    Give atropin, then Fentanyl, then Mivacurium

    Drug: Atropine, Fentanyl, Mivacurium

Interventions

  • DrugAtropine, Fentanyl, Mivacurium

    Drug pages: Atropine · Fentanyl · Mivacurium

    1. Atropin 10µg/kg 2. Mivacurium 200µg/kg immediately followed by 3. Fentanyl 2µg/kg

  • DrugAtropine, Fentanyl, Mivacurium

    Drug pages: Atropine · Fentanyl · Mivacurium

    1. Atropin 10µg/kg 2. Fentanyl 2µg/kg, repeat max. two times 3. Mivacurium 200µg/kg

06

What researchers measure

Primary outcomes

  1. Change of cerebral tissue oxygen saturation during premedication and intubation

    A baseline value of cerebral tissue oxygen saturation before first application of premedication drugs is determined. Change of cerebral tissue oxygen saturation is defined as area under this threshold from first drug application until recovery.

    Time frame: from 1 minute before first study drug until 10 minutes after end of procedure

07

Study locations

1 site
  • University Medical Center
    Ulm, Baden-Wurttemberg 89075, Germany
08

Timeline

Tracking since Sep 25, 2026
Not marked actual or estimatedDates not marked actual or estimated

The record gives a start of Jun 2011, a primary completion of Jul 2012 and a completion of Jul 2012. It does not say whether these dates are actual or estimated.

How these figures are worked out, and which studies are left out of them.

Registered
Aug 31, 2011
First posted
Sep 2, 2011
Start
Jun 2011
Primary completionActual
Jul 2012
CompletionActual
Jul 2012
Last update
Apr 6, 2016
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Apr 6, 2016, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT01427985
Lead sponsor
University of Ulm
Responsible party
Manuel Schmid (Dr. med., University of Ulm) — Principal investigator
First posted
Sep 2, 2011
Start date
Jun 2011
Primary completion
Jul 2012
Completion
Jul 2012
Last update
Apr 6, 2016

Study contacts

Manuel B Schmid, Dr. med.
principal investigator · University of Ulm

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Apr 2016. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Studies of the drugs tested here: Atropine · Fentanyl · Mivacurium

Start the discussion